PMID Title Authors Citation
38636933 Evaluating the association of body mass index with COVID-19 severity and mortality using Japanese administrative claims data Imoto W, Ihara Y, Imai T, Tamoto M, Ibuki T, Yamada K, Kaneko Y, Shintani A, Kakeya H. J Infect Chemother. 2024 Apr 16:S1341-321X(24)00115-6. doi: 10.1016/j.jiac.2024.04.007. Online ahead of print.
38538722 Factors impacting antibody kinetics, including fever and vaccination intervals, in SARS-CoV-2-naïve adults receiving the first four mRNA COVID-19 vaccine doses Matsuura T, Fukushima W, Nakagama Y, Kido Y, Kase T, Kondo K, Kaku N, Matsumoto K, Suita A, Mukai E, Nitahara Y, Konishi A, Kasamatsu A, Nakagama S, Nakagami-Yamaguchi E, Ohfuji S, Kaneko Y, Kaneko A, Kakeya H, Hirota Y. Sci Rep. 2024 Mar 27;14(1):7217. doi: 10.1038/s41598-024-57931-0.
37219067 Predictors of mortality from extended-spectrum beta-lactamase-producing Enterobacteriaceae bacteremia Namikawa H, Imoto W, Yamada K, Tochino Y, Kaneko Y, Kakeya H, Shuto T. Emerg Microbes Infect. 2023 Dec;12(1):2217951. doi: 10.1080/22221751.2023.2217951.
37210419 Identification of a mycobacterial hydrazidase, an isoniazid-hydrolyzing enzyme Sakiyama A, Saren C, Kaneko Y, Oinuma KI. Sci Rep. 2023 May 20;13(1):8180. doi: 10.1038/s41598-023-35213-5.
37028799 Impact of antimicrobial stewardship with the Xpert MRSA/SA BC assay at a tertiary hospital in Japan Yamada K, Imoto W, Shibata W, Kakuno S, Nakaie K, Myodo Y, Takayama N, Dobashi A, Imai M, Mitani K, Ogawa M, Niki M, Sakurai N, Nonose Y, Okada Y, Fujita A, Kaneko Y, Kakeya H. J Infect Chemother. 2023 Apr 6:S1341-321X(23)00085-5. doi: 10.1016/j.jiac.2023.03.021. Online ahead of print.
36858631 A Culture Supernatant from an Actinomycete sp. Affects Biofilm Formation and Virulence Expression of Candida auris Yamane K, Niki M, Tsubouchi T, Watanabe T, Asai K, Oinuma KI, Sakiyama A, Saren C, Matsumoto Y, Makimura K, Kaneko Y, Kawaguchi T. Med Mycol J. 2023;64(1):7-17. doi: 10.3314/mmj.22-00026.
36858159 Differences in severity of bacteraemia caused by hypermucoviscous and non-hypermucoviscous Klebsiella pneumoniae Namikawa H, Oinuma KI, Yamada K, Kaneko Y, Kakeya H, Shuto T. Int J Antimicrob Agents. 2023 Feb 28;61(5):106767. doi: 10.1016/j.ijantimicag.2023.106767. Online ahead of print.
36640992 Two cases of Clostridium ramosum bacteremia with intestinal perforation: The antimicrobial susceptibility of clinical strains Yamairi K, Niki M, Imoto W, Kuwabara G, Shibata W, Oshima K, Yamada K, Kaneko Y, Kakeya H. Anaerobe. 2023 Apr;80:102695. doi: 10.1016/j.anaerobe.2023.102695. Epub 2023 Jan 12.
36572148 Rifampicin exerts anti-mucoviscous activity against hypervirulent Klebsiella pneumoniae via binding to the RNA polymerase β subunit Tohda M, Oinuma KI, Sakiyama A, Tsubouchi T, Niki M, Namikawa H, Yamane K, Yamada K, Watanabe T, Asai K, Kakeya H, Kaneko Y, Kawaguchi T. J Glob Antimicrob Resist. 2023 Mar;32:21-28. doi: 10.1016/j.jgar.2022.11.018. Epub 2022 Dec 23.
36565806 Discovery of a LuxR-type regulator involved in isoniazid-dependent gene regulation in Mycobacterium smegmatis Sakiyama A, Oinuma KI, Kaneko Y. J Infect Chemother. 2023 Mar;29(3):322-328. doi: 10.1016/j.jiac.2022.12.011. Epub 2022 Dec 21.
36028457 Kinetics of anti-SARS-CoV-2 antibody titer in healthy adults up to 6 months after BNT162b2 vaccination measured by two immunoassays: A prospective cohort study in Japan Matsuura T, Fukushima W, Nakagama Y, Kido Y, Kase T, Kondo K, Kaku N, Matsumoto K, Suita A, Komiya E, Mukai E, Nitahara Y, Konishi A, Kasamatsu A, Nakagami-Yamaguchi E, Ohfuji S, Kaneko Y, Kaneko A, Kakeya H, Hirota Y. Vaccine. 2022 Sep 9;40(38):5631-5640. doi: 10.1016/j.vaccine.2022.08.018. Epub 2022 Aug 15.
34934945 Genomic characterization of triple-carbapenemase-producing Acinetobacter baumannii Oinuma KI, Suzuki M, Sakiyama A, Tsubouchi T, Saeki K, Sato K, Niki M, Yamada K, Shibayama K, Kakeya H, Kaneko Y. JAC Antimicrob Resist. 2021 Dec 18;3(4):dlab191. doi: 10.1093/jacamr/dlab191. eCollection 2021 Dec.
34591663 Complete Genome Sequence of a Clinical Isolate of Acinetobacter baumannii Harboring 11 Plasmids Sakiyama A, Matsumoto Y, Tsubouchi T, Suzuki M, Niki M, Niki M, Oinuma KI, Kakeya H, Kaneko Y. Microbiol Resour Announc. 2021 Sep 30;10(39):e0069521. doi: 10.1128/MRA.00695-21. Epub 2021 Sep 30.
34591662 Complete Genome Sequence of Acinetobacter pittii OCU_Ac17, Isolated from Human Venous Blood Matsumoto Y, Sakiyama A, Tsubouchi T, Suzuki M, Niki M, Niki M, Kakeya H, Kaneko Y. Microbiol Resour Announc. 2021 Sep 30;10(39):e0069621. doi: 10.1128/MRA.00696-21. Epub 2021 Sep 30.
34544939 Efficacy of Intravenous Itraconazole Versus Liposomal Amphotericin B as Empirical Antifungal Therapy in Hematological Malignancy with Persistent Fever and Neutropenia: Study Protocol for a Multicenter, Prospective, Randomized Non-inferiority Trial Saito AM, Yoshida I, Tanaka S, Sawamura M, Hidaka M, Yoshida S, Uike N, Kaneko Y, Miyazaki Y, Nagai H. Kurume Med J. 2021 Dec 15;66(4):239-246. doi: 10.2739/kurumemedj.MS664001. Epub 2021 Sep 21.
34449816 Correction: Significance of a histone-like protein with its native structure for the diagnosis of asymptomatic tuberculosis Ohara Y, Ozeki Y, Tateishi Y, Mashima T, Arisaka F, Tsunaka Y, Fujiwara Y, Nishiyama A, Yoshida Y, Kitadokoro K, Kobayashi H, Kaneko Y, Nakagawa I, Maekura R, Yamamoto S, Katahira M, Matsumoto S. PLoS One. 2021 Aug 27;16(8):e0256946. doi: 10.1371/journal.pone.0256946. eCollection 2021.
34272150 Siderophore production as a biomarker for Klebsiella pneumoniae strains that cause sepsis: A pilot study Namikawa H, Niki M, Niki M, Oinuma KI, Yamada K, Nakaie K, Tsubouchi T, Tochino Y, Takemoto Y, Kaneko Y, Kakeya H, Shuto T. J Formos Med Assoc. 2022 Apr;121(4):848-855. doi: 10.1016/j.jfma.2021.06.027. Epub 2021 Jul 13.
34137632 Complete Genome Sequence of Polycladomyces abyssicola JIR-001(T), Isolated from Hemipelagic Sediment in Deep Seawater Tsubouchi T, Kaneko Y. Microbiol Resour Announc. 2021 Jun 17;10(24):e0043521. doi: 10.1128/MRA.00435-21. Epub 2021 Jun 17.
33735789 Risk factor analysis for piperacillin-tazobactam-resistant Enterobacter spp. bacteremia at a tertiary hospital Yamairi K, Yamada K, Imoto W, Kuwabara G, Shibata W, Namikawa H, Oshima K, Nakaie K, Niki M, Kaneko Y, Kakeya H. Diagn Microbiol Infect Dis. 2021 Jun;100(2):115342. doi: 10.1016/j.diagmicrobio.2021.115342. Epub 2021 Feb 10.
33549416 Corynebacterium jeikeium-induced infective endocarditis and perivalvular abscess diagnosed by 16S ribosomal RNA sequence analysis: A case report Imoto W, Takahashi Y, Yamada K, Hojo K, Kawase T, Sakon Y, Kuwabara G, Yamairi K, Shibata W, Oshima K, Ogawa M, Niki M, Nakaie K, Watanabe T, Asai K, Kaneko Y, Kawaguchi T, Shibata T, Kakeya H. J Infect Chemother. 2021 Jun;27(6):906-910. doi: 10.1016/j.jiac.2021.01.005. Epub 2021 Feb 3.
33242675 A mouse model of rapidly progressive fatal haemorrhagic pneumonia caused by Stenotrophomonas maltophilia Imoto W, Kaneko Y, Yamada K, Kuwabara G, Yamairi K, Shibata W, Oshima K, Niki M, Nakaie K, Watanabe T, Asai K, Kawaguchi T, Kakeya H. J Glob Antimicrob Resist. 2020 Dec;23:450-455. doi: 10.1016/j.jgar.2020.10.024. Epub 2020 Nov 23.
33067106 Incidental finding of neurosyphilis with intracranial hemorrhage and cerebral infarction: A case report Imoto W, Arima H, Yamada K, Kanzaki T, Nakagawa C, Kuwabara G, Yamairi K, Shibata W, Oshima K, Watanabe T, Asai K, Kaneko Y, Kawaguchi T, Goto T, Kakeya H. J Infect Chemother. 2021 Mar;27(3):521-525. doi: 10.1016/j.jiac.2020.10.001. Epub 2020 Oct 14.
32950394 Three-year epidemiological analysis of Clostridioides difficile infection and the value of hospital-infection control measures in a tertiary-care teaching hospital in Japan using PCR-based open-reading frame typing Nakaie K, Yamada K, Kuwabara G, Imoto W, Yamairi K, Shibata W, Oshima K, Niki M, Sakurai N, Nonose Y, Okada Y, Fujita A, Kaneko Y, Kakeya H. J Infect Chemother. 2021 Feb;27(2):179-184. doi: 10.1016/j.jiac.2020.08.020. Epub 2020 Sep 17.
32777587 Blood culture reports by infectious disease physicians can improve prognosis of bacteremia, including weekend-onset cases Yamada K, Kuwabara G, Imoto W, Yamairi K, Shibata W, Oshima K, Yoshii N, Nakaie K, Niki M, Okada Y, Fujita A, Sakurai N, Kaneko Y, Kakeya H. Int J Infect Dis. 2020 Nov;100:174-179. doi: 10.1016/j.ijid.2020.08.013. Epub 2020 Aug 8.
32760105 Nutritional status positively impacts humoral immunity against its Mycobacterium tuberculosis, disease progression, and vaccine development Niki M, Yoshiyama T, Nagai H, Miyamoto Y, Niki M, Oinuma KI, Tsubouchi T, Kaneko Y, Matsumoto S, Sasaki Y, Hoshino Y. PLoS One. 2020 Aug 6;15(8):e0237062. doi: 10.1371/journal.pone.0237062. eCollection 2020.
32563248 Disseminated Mycobacterium abscessus subsp. massiliense infection in a Good's syndrome patient negative for human immunodeficiency virus and anti-interferon-γ autoantibody: a case report Imoto W, Yamada K, Hajika Y, Okamoto K, Myodo Y, Niki M, Kuwabara G, Yamairi K, Shibata W, Yoshii N, Nakaie K, Yoshizawa K, Namikawa H, Watanabe T, Asai K, Moro H, Kaneko Y, Kawaguchi T, Itoh Y, Kakeya H. BMC Infect Dis. 2020 Jun 20;20(1):431. doi: 10.1186/s12879-020-05136-x.
32446953 The effect of intervention by an antimicrobial stewardship team on anaerobic bacteremia Kuwabara G, Yukawa S, Yamada K, Imoto W, Yamairi K, Shibata W, Yoshii N, Watanabe T, Asai K, Niki M, Nakaie K, Okada Y, Fujita A, Kaneko Y, Kawaguchi T, Kakeya H. Anaerobe. 2020 Aug;64:102214. doi: 10.1016/j.anaerobe.2020.102214. Epub 2020 May 21.
32409539 Complete Genome Sequence of Acinetobacter baumannii ATCC 19606(T), a Model Strain of Pathogenic Bacteria Causing Nosocomial Infection Tsubouchi T, Suzuki M, Niki M, Oinuma KI, Niki M, Kakeya H, Kaneko Y. Microbiol Resour Announc. 2020 May 14;9(20):e00289-20. doi: 10.1128/MRA.00289-20.
32391919 Intravenous itraconazole compared with liposomal amphotericin B as empirical antifungal therapy in patients with neutropaenia and persistent fever Yoshida I, Saito AM, Tanaka S, Choi I, Hidaka M, Miyata Y, Inoue Y, Yamasaki S, Kagoo T, Iida H, Niimi H, Komeno T, Yoshida C, Tajima F, Yamamoto H, Takase K, Ueno H, Shimomura T, Sakai T, Nakashima Y, Yoshida C, Kubonishi S, Sunami K, Yoshida S, Sakurai A, Kaneko Y, Miyazaki Y, Nagai H. Mycoses. 2020 Aug;63(8):794-801. doi: 10.1111/myc.13100. Epub 2020 May 28.
32060526 Detection of Rhizopus-specific antigen in human and murine serum and bronchoalveolar lavage Shibata W, Niki M, Sato K, Fujimoto H, Yamada K, Watanabe T, Miyazaki Y, Asai K, Obata Y, Tachibana T, Kawaguchi T, Kaneko Y, Kakeya H. Med Mycol. 2020 Oct 1;58(7):958-964. doi: 10.1093/mmy/myaa001.
31941869 Clinical Characteristics of Rapidly Progressive Fatal Hemorrhagic Pneumonia Caused by Stenotrophomonas maltophilia Imoto W, Yamada K, Yamairi K, Shibata W, Namikawa H, Yukawa S, Yoshii N, Nakaie K, Hirose A, Koh H, Watanabe T, Asai K, Nakamae H, Kaneko Y, Kawaguchi T, Hino M, Kakeya H. Intern Med. 2020;59(2):193-198. doi: 10.2169/internalmedicine.3358-19. Epub 2020 Jan 15.
31605255 Clinical and virulence factors related to the 30-day mortality of Klebsiella pneumoniae bacteremia at a tertiary hospital: a case-control study Namikawa H, Niki M, Niki M, Yamada K, Nakaie K, Sakiyama A, Oinuma KI, Tsubouchi T, Tochino Y, Takemoto Y, Kaneko Y, Shuto T, Kakeya H. Eur J Clin Microbiol Infect Dis. 2019 Dec;38(12):2291-2297. doi: 10.1007/s10096-019-03676-y. Epub 2019 Oct 11.
31256940 Clinical characteristics of bacteremia caused by hypermucoviscous Klebsiella pneumoniae at a tertiary hospital Namikawa H, Yamada K, Sakiyama A, Imoto W, Yamairi K, Shibata W, Yoshii N, Niki M, Nakaie K, Oinuma KI, Tsubouchi T, Niki M, Tochino Y, Takemoto Y, Kaneko Y, Shuto T, Kakeya H. Diagn Microbiol Infect Dis. 2019 Sep;95(1):84-88. doi: 10.1016/j.diagmicrobio.2019.04.008. Epub 2019 Apr 26.
31255524 The intervention by an antimicrobial stewardship team can improve clinical and microbiological outcomes of resistant gram-negative bacteria Yamada K, Imoto W, Yamairi K, Shibata W, Namikawa H, Yoshii N, Fujimoto H, Nakaie K, Okada Y, Fujita A, Kawaguchi H, Shinoda Y, Nakamura Y, Kaneko Y, Yoshida H, Kakeya H. J Infect Chemother. 2019 Dec;25(12):1001-1006. doi: 10.1016/j.jiac.2019.05.026. Epub 2019 Jun 26.
31173862 Discovery of anti-mucoviscous activity of rifampicin and its potential as a candidate antivirulence agent against hypervirulent Klebsiella pneumoniae Namikawa H, Oinuma KI, Sakiyama A, Tsubouchi T, Tahara YO, Yamada K, Niki M, Takemoto Y, Miyata M, Kaneko Y, Shuto T, Kakeya H. Int J Antimicrob Agents. 2019 Aug;54(2):167-175. doi: 10.1016/j.ijantimicag.2019.05.018. Epub 2019 Jun 5.
31005401 Mortality caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae bacteremia; a case control study: alert to Enterobacteriaceae strains with high minimum inhibitory concentrations of piperacillin/tazobactam Namikawa H, Yamada K, Yamairi K, Shibata W, Fujimoto H, Takizawa E, Niki M, Nakaie K, Oinuma KI, Niki M, Takemoto Y, Kaneko Y, Shuto T, Kakeya H. Diagn Microbiol Infect Dis. 2019 Jul;94(3):287-292. doi: 10.1016/j.diagmicrobio.2019.01.018. Epub 2019 Jan 30.
30814458 Genome-Based Epidemiological Analysis of 13 Acinetobacter Strains Isolated from Blood Cultures of Hospitalized Patients from a University Hospital in Japan Oinuma KI, Suzuki M, Nakaie K, Sato K, Saeki K, Sakiyama A, Takizawa E, Niki M, Niki M, Yamada K, Shibayama K, Kakeya H, Kaneko Y. Jpn J Infect Dis. 2019 Jul 24;72(4):274-280. doi: 10.7883/yoken.JJID.2018.403. Epub 2019 Feb 28.
30803878 The effects of antifungal stewardship programs at a tertiary-care teaching hospital in Japan Kawaguchi H, Yamada K, Imoto W, Yamairi K, Shibata W, Namikawa H, Yoshii N, Nakaie K, Okada Y, Fujita A, Shinoda Y, Nakamura Y, Kaneko Y, Nagayama K, Kakeya H. J Infect Chemother. 2019 Jun;25(6):458-462. doi: 10.1016/j.jiac.2019.01.015. Epub 2019 Feb 23.
30611637 Molecular and epidemiological analysis of IMP-1 metallo-β-lactamase-producing Klebsiella pneumoniae in a tertiary care hospital in Japan Yamakawa H, Kosai K, Akamatsu N, Matsuda J, Kaku N, Uno N, Morinaga Y, Hasegawa H, Tsubouchi T, Kaneko Y, Miyazaki T, Izumikawa K, Mukae H, Yanagihara K. J Infect Chemother. 2019 Apr;25(4):240-246. doi: 10.1016/j.jiac.2018.11.012. Epub 2019 Jan 2.
30503017 Successful treatment of invasive pulmonary aspergillosis caused by Aspergillus felis, a cryptic species within the Aspergillus section Fumigati: A case report Yamairi K, Ido K, Nakamura S, Niki M, Imoto W, Shibata W, Namikawa H, Fujimoto H, Yamada K, Nakamae H, Hino M, Kaneko Y, Miyazaki Y, Kakeya H. J Infect Chemother. 2019 Apr;25(4):307-310. doi: 10.1016/j.jiac.2018.10.016. Epub 2018 Nov 30.
30359374 Significance of a histone-like protein with its native structure for the diagnosis of asymptomatic tuberculosis Ohara Y, Ozeki Y, Tateishi Y, Mashima T, Arisaka F, Tsunaka Y, Fujiwara Y, Nishiyama A, Yoshida Y, Kitadokoro K, Kobayashi H, Kaneko Y, Nakagawa I, Maekura R, Yamamoto S, Katahira M, Matsumoto S. PLoS One. 2018 Oct 25;13(10):e0204160. doi: 10.1371/journal.pone.0204160. eCollection 2018.
30257953 Gallium disrupts bacterial iron metabolism and has therapeutic effects in mice and humans with lung infections Goss CH, Kaneko Y, Khuu L, Anderson GD, Ravishankar S, Aitken ML, Lechtzin N, Zhou G, Czyz DM, McLean K, Olakanmi O, Shuman HA, Teresi M, Wilhelm E, Caldwell E, Salipante SJ, Hornick DB, Siehnel RJ, Becker L, Britigan BE, Singh PK. Sci Transl Med. 2018 Sep 26;10(460):eaat7520. doi: 10.1126/scitranslmed.aat7520.
30069487 Longitudinal Evaluation of Humoral Immunity and Bacterial and Clinical Parameters Reveals That Antigen-Specific Antibodies Suppress Inflammatory Responses in Active Tuberculosis Patients Niki M, Yoshiyama T, Miyamoto Y, Okumura M, Niki M, Oinuma KI, Kaneko Y, Matsumoto S, Sasaki Y, Ogata H, Goto H, Kudoh S, Hoshino Y. J Immunol Res. 2018 Jul 4;2018:4928757. doi: 10.1155/2018/4928757. eCollection 2018.
29712918 High-density lipoprotein suppresses tumor necrosis factor alpha production by mycobacteria-infected human macrophages Inoue M, Niki M, Ozeki Y, Nagi S, Chadeka EA, Yamaguchi T, Osada-Oka M, Ono K, Oda T, Mwende F, Kaneko Y, Matsumoto M, Kaneko S, Ichinose Y, Njenga SM, Hamano S, Matsumoto S. Sci Rep. 2018 Apr 30;8(1):6736. doi: 10.1038/s41598-018-24233-1.
29526942 Successful Treatment of Intestinal Mycosis Caused by a Simultaneous Infection with Lichtheimia ramosa and Aspergillus calidoustus Kaneko Y, Oinuma KI, Terachi T, Arimura Y, Niki M, Yamada K, Kakeya H, Mizutani T. Intern Med. 2018 Aug 15;57(16):2421-2424. doi: 10.2169/internalmedicine.0254-17. Epub 2018 Mar 9.
29187672 Clinical Characteristics and Low Susceptibility to Daptomycin in Enterococcus faecium Bacteremia Namikawa H, Yamada K, Shibata W, Fujimoto H, Takizawa E, Niki M, Nakaie K, Nakamura Y, Oinuma KI, Niki M, Takemoto Y, Kaneko Y, Shuto T, Kakeya H. Tohoku J Exp Med. 2017 Nov;243(3):211-218. doi: 10.1620/tjem.243.211.
29167254 Draft Genome Sequence of the Arsenic-Resistant Bacterium Brevundimonas denitrificans TAR-002(T) Tsubouchi T, Kaneko Y. Genome Announc. 2017 Nov 22;5(47):e01326-17. doi: 10.1128/genomeA.01326-17.
28717075 Clinical Characteristics of Bacteremia Caused by Extended-spectrum Beta-lactamase-producing Escherichia coli at a Tertiary Hospital Namikawa H, Yamada K, Fujimoto H, Oinuma KI, Tochino Y, Takemoto Y, Kaneko Y, Shuto T, Kakeya H. Intern Med. 2017;56(14):1807-1815. doi: 10.2169/internalmedicine.56.7702. Epub 2017 Jul 15.
28381743 Clinical Characteristics of Methicillin-resistant Coagulase-negative Staphylococcal Bacteremia in a Tertiary Hospital Yamada K, Namikawa H, Fujimoto H, Nakaie K, Takizawa E, Okada Y, Fujita A, Kawaguchi H, Nakamura Y, Abe J, Kaneko Y, Kakeya H. Intern Med. 2017;56(7):781-785. doi: 10.2169/internalmedicine.56.7715. Epub 2017 Apr 1.
28199672 Identification of a Novel Rhizopus-specific Antigen by Screening with a Signal Sequence Trap and Evaluation as a Possible Diagnostic Marker of Mucormycosis Sato K, Oinuma KI, Niki M, Yamagoe S, Miyazaki Y, Asai K, Yamada K, Hirata K, Kaneko Y, Kakeya H. Med Mycol. 2017 Oct 1;55(7):713-719. doi: 10.1093/mmy/myw146.
28155911 Effects of nutritional and ambient oxygen condition on biofilm formation in Mycobacterium avium subsp. hominissuis via altered glycolipid expression Totani T, Nishiuchi Y, Tateishi Y, Yoshida Y, Kitanaka H, Niki M, Kaneko Y, Matsumoto S. Sci Rep. 2017 Feb 3;7:41775. doi: 10.1038/srep41775.
27856588 Genome Sequence of an Acinetobacter baumannii Strain Carrying Three Acquired Carbapenemase Genes Oinuma KI, Suzuki M, Sato K, Nakaie K, Niki M, Takizawa E, Niki M, Shibayama K, Yamada K, Kakeya H, Kaneko Y. Genome Announc. 2016 Nov 17;4(6):e01290-16. doi: 10.1128/genomeA.01290-16.
27852233 Two unusual cases of successful treatment of hypermucoviscous Klebsiella pneumoniae invasive syndrome Namikawa H, Yamada K, Fujimoto H, Oinuma KI, Tochino Y, Takemoto Y, Kaneko Y, Shuto T, Kakeya H. BMC Infect Dis. 2016 Nov 16;16(1):680. doi: 10.1186/s12879-016-2011-3.
27693014 Effectiveness of weekly polymerase chain reaction-based open reading frame typing analysis of all newly isolated methicillin-resistant Staphylococcus aureus strains for controlling nosocomial infections Nakaie K, Yamada K, Park K, Nakamura Y, Okada Y, Fujita A, Fujimoto H, Kaneko Y, Kakeya H. J Infect Chemother. 2016 Nov;22(11):733-737. doi: 10.1016/j.jiac.2016.07.007. Epub 2016 Sep 28.
27523013 An Intrinsic Strain of Colistin-resistant Acinetobacter Isolated from a Japanese Patient Takizawa E, Yamada K, Oinuma K, Sato K, Niki M, Namikawa H, Fujimoto H, Asai K, Kaneko Y, Kakeya H. Intern Med. 2016;55(16):2301-6. doi: 10.2169/internalmedicine.55.6807. Epub 2016 Aug 15.
26833283 Effects of Temperature and Humidity History on Brittleness of α-Sulfonated Fatty Acid Methyl Ester Salt Crystals Watanabe H, Morigaki A, Kaneko Y, Tobori N, Aramaki K. J Oleo Sci. 2016;65(2):143-50. doi: 10.5650/jos.ess15214.
26779451 Evasion of Innate Immune Responses by the Highly Virulent Cryptococcus gattii by Altering Capsule Glucuronoxylomannan Structure Urai M, Kaneko Y, Ueno K, Okubo Y, Aizawa T, Fukazawa H, Sugita T, Ohno H, Shibuya K, Kinjo Y, Miyazaki Y. Front Cell Infect Microbiol. 2016 Jan 6;5:101. doi: 10.3389/fcimb.2015.00101. eCollection 2015.
26568961 Evaluation of Humoral Immunity to Mycobacterium tuberculosis-Specific Antigens for Correlation with Clinical Status and Effective Vaccine Development Niki M, Suzukawa M, Akashi S, Nagai H, Ohta K, Inoue M, Niki M, Kaneko Y, Morimoto K, Kurashima A, Kitada S, Matsumoto S, Suzuki K, Hoshino Y. J Immunol Res. 2015;2015:527395. doi: 10.1155/2015/527395. Epub 2015 Oct 19.
25876577 Successful treatment of Cryptococcus laurentii peritonitis in a patient on peritoneal dialysis Asano M, Mizutani M, Nagahara Y, Inagaki K, Kariya T, Masamoto D, Urai M, Kaneko Y, Ohno H, Miyazaki Y, Mizuno M, Ito Y. Intern Med. 2015;54(8):941-4. doi: 10.2169/internalmedicine.54.3586. Epub 2015 Apr 15.
25828927 Invasive pulmonary aspergillosis due to Aspergillus lentulus: Successful treatment of a liver transplant patient Yoshida H, Seki M, Umeyama T, Urai M, Kinjo Y, Nishi I, Toyokawa M, Kaneko Y, Ohno H, Miyazaki Y, Tomono K. J Infect Chemother. 2015 Jun;21(6):479-81. doi: 10.1016/j.jiac.2015.02.010. Epub 2015 Mar 6.
25644007 Dendritic cell-based immunization ameliorates pulmonary infection with highly virulent Cryptococcus gattii Ueno K, Kinjo Y, Okubo Y, Aki K, Urai M, Kaneko Y, Shimizu K, Wang DN, Okawara A, Nara T, Ohkouchi K, Mizuguchi Y, Kawamoto S, Kamei K, Ohno H, Niki Y, Shibuya K, Miyazaki Y. Infect Immun. 2015 Apr;83(4):1577-86. doi: 10.1128/IAI.02827-14. Epub 2015 Feb 2.
25009090 Potent drugs that attenuate anti-Candida albicans activity of fluconazole and their possible mechanisms of action Urai M, Kaneko Y, Niki M, Inoue M, Tanabe K, Umeyama T, Fukazawa H, Ohno H, Miyazaki Y. J Infect Chemother. 2014 Oct;20(10):612-5. doi: 10.1016/j.jiac.2014.06.004. Epub 2014 Jul 5.
24177211 Retinoids and rexinoids inhibit hepatitis C virus independently of retinoid receptor signaling Murakami Y, Fukasawa M, Kaneko Y, Suzuki T, Wakita T, Fukazawa H. Microbes Infect. 2014 Feb;16(2):114-22. doi: 10.1016/j.micinf.2013.10.016. Epub 2013 Oct 28.
24058271 How histopathology can contribute to an understanding of defense mechanisms against cryptococci Okubo Y, Tochigi N, Wakayama M, Shinozaki M, Nakayama H, Ishiwatari T, Shimodaira K, Nemoto T, Ohno H, Kaneko Y, Makimura K, Uchida K, Miyazaki Y, Yamaguchi H, Shibuya K. Mediators Inflamm. 2013;2013:465319. doi: 10.1155/2013/465319. Epub 2013 Aug 22.
23807392 Combinatory effect of fluconazole and FDA-approved drugs against Candida albicans Kaneko Y, Fukazawa H, Ohno H, Miyazaki Y. J Infect Chemother. 2013 Dec;19(6):1141-5. doi: 10.1007/s10156-013-0639-0. Epub 2013 Jun 27.
23698482 Histopathological study of murine pulmonary cryptococcosis induced by Cryptococcus gattii and Cryptococcus neoformans Okubo Y, Wakayama M, Ohno H, Yamamoto S, Tochigi N, Tanabe K, Kaneko Y, Yamagoe S, Umeyama T, Shinozaki M, Nemoto T, Nakayama H, Sasai D, Ishiwatari T, Shimodaira K, Yamamoto Y, Kamei K, Miyazaki Y, Shibuya K. Jpn J Infect Dis. 2013;66(3):216-21. doi: 10.7883/yoken.66.216.
23689715 Efficacy of AiiM, an N-acylhomoserine lactonase, against Pseudomonas aeruginosa in a mouse model of acute pneumonia Migiyama Y, Kaneko Y, Yanagihara K, Morohoshi T, Morinaga Y, Nakamura S, Miyazaki T, Hasegawa H, Izumikawa K, Kakeya H, Kohrogi H, Kohno S. Antimicrob Agents Chemother. 2013 Aug;57(8):3653-8. doi: 10.1128/AAC.00456-13. Epub 2013 May 20.
23459484 Real-time microscopic observation of Candida biofilm development and effects due to micafungin and fluconazole Kaneko Y, Miyagawa S, Takeda O, Hakariya M, Matsumoto S, Ohno H, Miyazaki Y. Antimicrob Agents Chemother. 2013 May;57(5):2226-30. doi: 10.1128/AAC.02290-12. Epub 2013 Mar 4.
23429086 Determination of epidemiology of clinically isolated Cryptococcus neoformans strains in Japan by multilocus sequence typing Umeyama T, Ohno H, Minamoto F, Takagi T, Tanamachi C, Tanabe K, Kaneko Y, Yamagoe S, Kishi K, Fujii T, Takemura H, Watanabe H, Miyazaki Y. Jpn J Infect Dis. 2013;66(1):51-5. doi: 10.7883/yoken.66.51.
23345048 Application of nested PCR for diagnosis of histoplasmosis Ohno H, Tanabe K, Umeyama T, Kaneko Y, Yamagoe S, Miyazaki Y. J Infect Chemother. 2013 Oct;19(5):999-1003. doi: 10.1007/s10156-013-0548-2. Epub 2013 Jan 24.
23103222 Selective estrogen receptor modulators inhibit hepatitis C virus infection at multiple steps of the virus life cycle Murakami Y, Fukasawa M, Kaneko Y, Suzuki T, Wakita T, Fukazawa H. Microbes Infect. 2013 Jan;15(1):45-55. doi: 10.1016/j.micinf.2012.10.003. Epub 2012 Oct 23.
21892173 Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria Kinjo Y, Illarionov P, Vela JL, Pei B, Girardi E, Li X, Li Y, Imamura M, Kaneko Y, Okawara A, Miyazaki Y, Gómez-Velasco A, Rogers P, Dahesh S, Uchiyama S, Khurana A, Kawahara K, Yesilkaya H, Andrew PW, Wong CH, Kawakami K, Nizet V, Besra GS, Tsuji M, Zajonc DM, Kronenberg M. Nat Immunol. 2011 Sep 4;12(10):966-74. doi: 10.1038/ni.2096.
21798258 Imaging mass spectrometry analysis reveals an altered lipid distribution pattern in the tubular areas of hyper-IgA murine kidneys Kaneko Y, Obata Y, Nishino T, Kakeya H, Miyazaki Y, Hayasaka T, Setou M, Furusu A, Kohno S. Exp Mol Pathol. 2011 Oct;91(2):614-21. doi: 10.1016/j.yexmp.2011.07.002. Epub 2011 Jul 23.
20859005 Micafungin alters the expression of genes related to cell wall integrity in Candida albicans biofilms Kaneko Y, Ohno H, Kohno S, Miyazaki Y. Jpn J Infect Dis. 2010 Sep;63(5):355-7.
20190491 An outbreak of histoplasmosis among healthy young Japanese women after traveling to Southeast Asia Ohno H, Ogata Y, Suguro H, Yokota S, Watanabe A, Kamei K, Yamagoe S, Ishida-Okawara A, Kaneko Y, Horino A, Yamane K, Tsuji T, Nagata N, Hasegawa H, Arakawa Y, Sata T, Miyazaki Y. Intern Med. 2010;49(5):491-5. doi: 10.2169/internalmedicine.49.2759. Epub 2010 Mar 1.
19958255 Anti-Candida-biofilm activity of micafungin is attenuated by voriconazole but restored by pharmacological inhibition of Hsp90-related stress responses Kaneko Y, Ohno H, Fukazawa H, Murakami Y, Imamura Y, Kohno S, Miyazaki Y. Med Mycol. 2010 Jun;48(4):606-12. doi: 10.3109/13693780903426721.
19762993 The effects of an hsp90 inhibitor on the paradoxical effect Kaneko Y, Ohno H, Imamura Y, Kohno S, Miyazaki Y. Jpn J Infect Dis. 2009 Sep;62(5):392-3.
19706543 Targeting a bacterial stress response to enhance antibiotic action Lee S, Hinz A, Bauerle E, Angermeyer A, Juhaszova K, Kaneko Y, Singh PK, Manoil C. Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14570-5. doi: 10.1073/pnas.0903619106. Epub 2009 Aug 12.
17364024 The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity Kaneko Y, Thoendel M, Olakanmi O, Britigan BE, Singh PK. J Clin Invest. 2007 Apr;117(4):877-88. doi: 10.1172/JCI30783. Epub 2007 Mar 15.
17052786 A case of transient left ventricular ballooning with pheochromocytoma, supporting pathogenetic role of catecholamines in stress-induced cardiomyopathy or takotsubo cardiomyopathy Takizawa M, Kobayakawa N, Uozumi H, Yonemura S, Kodama T, Fukusima K, Takeuchi H, Kaneko Y, Kaneko T, Fujita K, Honma Y, Aoyagi T. Int J Cardiol. 2007 Jan 2;114(1):e15-7. doi: 10.1016/j.ijcard.2006.07.125. Epub 2006 Oct 18.
16862214 Bacterial neuraminidase facilitates mucosal infection by participating in biofilm production Soong G, Muir A, Gomez MI, Waks J, Reddy B, Planet P, Singh PK, Kaneko Y, Wolfgang MC, Hsiao YS, Tong L, Prince A. J Clin Invest. 2006 Aug;116(8):2297-2305. doi: 10.1172/JCI27920.
15528893 Efficacy of quinupristin-dalfopristin against methicillin-resistant Staphylococcus aureus and vancomycin-insensitive S. aureus in a model of hematogenous pulmonary infection Yanagihara K, Okada M, Fukuda Y, Imamura Y, Kaneko Y, Ohno H, Higashiyama Y, Miyazaki Y, Tsukamoto K, Hirakata Y, Tomono K, Kadota J, Tashiro T, Murata I, Kohno S. Chemotherapy. 2004 Nov;50(5):260-4. doi: 10.1159/000081948. Epub 2004 Nov 3.
14665771 Overproduction of MUC5AC core protein in patients with diffuse panbronchiolitis Kaneko Y, Yanagihara K, Miyazaki Y, Hirakata Y, Mukae H, Tomono K, Okada Y, Kadota J, Kohno S. Respiration. 2003 Sep-Oct;70(5):475-8. doi: 10.1159/000074202.
14638467 Effects of DQ-113, a new quinolone, against methicillin- and vancomycin-resistant Staphylococcus aureus-caused hematogenous pulmonary infections in mice Kaneko Y, Yanagihara K, Miyazaki Y, Tsukamoto K, Hirakata Y, Tomono K, Kadota J, Tashiro T, Murata I, Kohno S. Antimicrob Agents Chemother. 2003 Dec;47(12):3694-8. doi: 10.1128/AAC.47.12.3694-3698.2003.
12818892 Clarithromycin inhibits overproduction of muc5ac core protein in murine model of diffuse panbronchiolitis Kaneko Y, Yanagihara K, Seki M, Kuroki M, Miyazaki Y, Hirakata Y, Mukae H, Tomono K, Kadota J, Kohno S. Am J Physiol Lung Cell Mol Physiol. 2003 Oct;285(4):L847-53. doi: 10.1152/ajplung.00216.2002. Epub 2003 Jun 20.
12748275 Role of elastase in a mouse model of chronic respiratory Pseudomonas aeruginosa infection that mimics diffuse panbronchiolitis Yanagihara K, Tomono K, Kaneko Y, Miyazaki Y, Tsukamoto K, Hirakata Y, Mukae H, Kadota JI, Murata I, Kohno S. J Med Microbiol. 2003 Jun;52(Pt 6):531-535. doi: 10.1099/jmm.0.05154-0.
12234863 Efficacy of linezolid against methicillin-resistant or vancomycin-insensitive Staphylococcus aureus in a model of hematogenous pulmonary infection Yanagihara K, Kaneko Y, Sawai T, Miyazaki Y, Tsukamoto K, Hirakata Y, Tomono K, Kadota J, Tashiro T, Murata I, Kohno S. Antimicrob Agents Chemother. 2002 Oct;46(10):3288-91. doi: 10.1128/AAC.46.10.3288-3291.2002.
12003986 Effect of clarithromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model Yanagihara K, Tomono K, Imamura Y, Kaneko Y, Kuroki M, Sawai T, Miyazaki Y, Hirakata Y, Mukae H, Kadota J, Kohno S. J Antimicrob Chemother. 2002 May;49(5):867-70. doi: 10.1093/jac/dkf013.

2023年4月27日　作成